Literature DB >> 20693993

Transgenic mice with a diverse human T cell antigen receptor repertoire.

Liang-Ping Li1, J Christoph Lampert, Xiaojing Chen, Catarina Leitao, Jelena Popović, Werner Müller, Thomas Blankenstein.   

Abstract

Because of tolerance mechanisms, it has been hard to identify the T cell receptors (TCRs) of high-avidity T cells against self (for example, tumor) antigens. TCRs that are specific for foreign human antigens from the nontolerant T cell repertoire can be identified in mice. Moreover, if mice are constructed to express the human TCR repertoire, they can be used to analyze the unskewed repertoire against human self antigens. Here we generated transgenic mice with the entire human TCRalphabeta gene loci (1.1 and 0.7 Mb), whose T cells express a diverse human TCR repertoire that compensates for mouse TCR deficiency. A human major histocompatibility class I transgene increases the generation of CD8+ T cells with human compared to mouse TCRs. Functional CD8+ T cells against several human tumor antigens were induced, and those against the Melan-A melanoma antigen used similar TCRs to those that have been detected in T cell clones from individuals with autoimmune vitiligo or melanoma. These mice will allow researchers to identify pathogenic and therapeutic human TCRs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20693993     DOI: 10.1038/nm.2197

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  34 in total

1.  A direct estimate of the human alphabeta T cell receptor diversity.

Authors:  T P Arstila; A Casrouge; V Baron; J Even; J Kanellopoulos; P Kourilsky
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

2.  Positive selection of antigen-specific T cells in thymus by restricting MHC molecules.

Authors:  P Kisielow; H S Teh; H Blüthmann; H von Boehmer
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

Review 3.  Positive selection of thymocytes.

Authors:  S C Jameson; K A Hogquist; M J Bevan
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

4.  Isolation of cDNA clones encoding T cell-specific membrane-associated proteins.

Authors:  S M Hedrick; D I Cohen; E A Nielsen; M M Davis
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

5.  Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages.

Authors:  P Mombaerts; A R Clarke; M A Rudnicki; J Iacomini; S Itohara; J J Lafaille; L Wang; Y Ichikawa; R Jaenisch; M L Hooper
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

6.  Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes.

Authors:  J Alexander; C Oseroff; J Sidney; P Wentworth; E Keogh; G Hermanson; F V Chisari; R T Kubo; H M Grey; A Sette
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

7.  Antigen-specific human antibodies from mice comprising four distinct genetic modifications.

Authors:  N Lonberg; L D Taylor; F A Harding; M Trounstine; K M Higgins; S R Schramm; C C Kuo; R Mashayekh; K Wymore; J G McCabe
Journal:  Nature       Date:  1994-04-28       Impact factor: 49.962

8.  A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains.

Authors:  Y Yanagi; Y Yoshikai; K Leggett; S P Clark; I Aleksander; T W Mak
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

9.  Evidence that gammadelta versus alphabeta T cell fate determination is initiated independently of T cell receptor signaling.

Authors:  J Kang; A Volkmann; D H Raulet
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

10.  On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition?

Authors:  R M Zinkernagel; G N Callahan; A Althage; S Cooper; P A Klein; J Klein
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  47 in total

1.  Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression.

Authors:  Lucia Poncette; Xiaojing Chen; Felix Km Lorenz; Thomas Blankenstein
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

2.  Complete rejection of large established breast cancer by local immunochemotherapy with T cell activation against neoantigens.

Authors:  Junxia Gao; Xianlin Yuan; Jia Yuan; Liangping Li
Journal:  Cancer Immunol Immunother       Date:  2021-04-14       Impact factor: 6.968

3.  High-throughput identification of antigen-specific TCRs by TCR gene capture.

Authors:  Carsten Linnemann; Bianca Heemskerk; Pia Kvistborg; Roelof J C Kluin; Dmitriy A Bolotin; Xiaojing Chen; Kaspar Bresser; Marja Nieuwland; Remko Schotte; Samira Michels; Raquel Gomez-Eerland; Lorenz Jahn; Pleun Hombrink; Nicolas Legrand; Chengyi Jenny Shu; Ilgar Z Mamedov; Arno Velds; Christian U Blank; John B A G Haanen; Maria A Turchaninova; Ron M Kerkhoven; Hergen Spits; Sine Reker Hadrup; Mirjam H M Heemskerk; Thomas Blankenstein; Dmitriy M Chudakov; Gavin M Bendle; Ton N M Schumacher
Journal:  Nat Med       Date:  2013-10-13       Impact factor: 53.440

4.  Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.

Authors:  Rieuwert Hoppes; Rimke Oostvogels; Jolien J Luimstra; Kim Wals; Mireille Toebes; Laura Bies; Reggy Ekkebus; Pramila Rijal; Patrick H N Celie; Julie H Huang; Maarten E Emmelot; Robbert M Spaapen; Henk Lokhorst; Ton N M Schumacher; Tuna Mutis; Boris Rodenko; Huib Ovaa
Journal:  J Immunol       Date:  2014-10-13       Impact factor: 5.422

5.  High-affinity T cell receptors for adoptive cell transfer.

Authors:  Ariel Isser; Jonathan P Schneck
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

Review 6.  The determinants of tumour immunogenicity.

Authors:  Thomas Blankenstein; Pierre G Coulie; Eli Gilboa; Elizabeth M Jaffee
Journal:  Nat Rev Cancer       Date:  2012-03-01       Impact factor: 60.716

Review 7.  Engineered T cells for anti-cancer therapy.

Authors:  Cameron J Turtle; Michael Hudecek; Michael C Jensen; Stanley R Riddell
Journal:  Curr Opin Immunol       Date:  2012-07-18       Impact factor: 7.486

8.  Isolation of human MHC class II-restricted T cell receptors from the autologous T-cell repertoire with potent anti-leukaemic reactivity.

Authors:  Luise U Weigand; Xiaoling Liang; Sabine Schmied; Sabine Mall; Richard Klar; Oliver J Stötzer; Christoph Salat; Katharina Götze; Josef Mautner; Christian Peschel; Angela M Krackhardt
Journal:  Immunology       Date:  2012-11       Impact factor: 7.397

Review 9.  Engineered T cells for cancer treatment.

Authors:  Usanarat Anurathapan; Ann M Leen; Malcolm K Brenner; Juan F Vera
Journal:  Cytotherapy       Date:  2013-11-13       Impact factor: 5.414

10.  A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control.

Authors:  Jennifer D Stone; Daniel T Harris; Carolina M Soto; Adam S Chervin; David H Aggen; Edward J Roy; David M Kranz
Journal:  Cancer Immunol Immunother       Date:  2014-08-01       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.